Cefotetan
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Urinary tract infections
- Lower respiratory tract infections
- Skin and skin-structure infections
- Gynecologic infections including PID (note: no activity against C. trachomatis)
- Intra-abdominal infections (IDSA guidelines: cefotetan is no longer recommended for intra-abdominal infections as monotherapy due to high rates of B. fragilis resistance).
- Bone and joint infections (author’s comment: generally used for mild infections)
- Surgical prophylaxis (e.g., cesarean section, abdominal or vaginal hysterectomy, trans-urethral surgery, biliary tract surgery, and gastrointestinal surgery)
NON-FDA APPROVED USES
- Uncomplicated cholangitis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Urinary tract infections
- Lower respiratory tract infections
- Skin and skin-structure infections
- Gynecologic infections including PID (note: no activity against C. trachomatis)
- Intra-abdominal infections (IDSA guidelines: cefotetan is no longer recommended for intra-abdominal infections as monotherapy due to high rates of B. fragilis resistance).
- Bone and joint infections (author’s comment: generally used for mild infections)
- Surgical prophylaxis (e.g., cesarean section, abdominal or vaginal hysterectomy, trans-urethral surgery, biliary tract surgery, and gastrointestinal surgery)
NON-FDA APPROVED USES
- Uncomplicated cholangitis
There's more to see -- the rest of this entry is available only to subscribers.